The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Novartis

A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.
 
Andrew Barbour
No Relationships to Disclose
 
Nicholas O'Rourke
No Relationships to Disclose
 
Jaswinder S. Samra
No Relationships to Disclose
 
Koroush S Haghighi
No Relationships to Disclose
 
James Kench
Honoraria - Pfizer
 
Jenna Mitchell
Research Funding - Specialised Therapeutics (Inst)
 
Nick Pavlakis
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Specialised Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Sanofi; Specialised Therapeutics
 
Matthew E. Burge
Stock and Other Ownership Interests - Cochlear; Cochlear (I); CSL Limited; CSL Limited (I); ResMed; ResMed (I); Sirtex Medical; Sirtex Medical (I)
Honoraria - GlaxoSmithKline; Sanofi
Consulting or Advisory Role - Roche; Specialised Therapeutics
Research Funding - Celgene (Inst); Genentech (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Ipsen; Roche
 
Jonathan Fawcett
No Relationships to Disclose
 
Sivikumar Gananadha
No Relationships to Disclose
 
Marion Harris
No Relationships to Disclose
 
Morteza Aghmesheh
No Relationships to Disclose
 
Yu Jo Chua
Consulting or Advisory Role - Specialised Therapeutics
 
Warren Lance Joubert
Consulting or Advisory Role - Specialised Therapeutics
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Matthew MK Chan
Travel, Accommodations, Expenses - Merck
 
Manju Dashini Chandrasegaram
No Relationships to Disclose
 
Sonia Yip
Speakers' Bureau - Lilly
 
John Simes
Research Funding - Abbott Diagnostics (Inst); Amgen (Inst); Australia & New Zealand Breast Cancer Trials Group (Inst); Australian Department of Health and Ageing (Inst); Australian Gastro-Intestinal Trials Group (Inst); Bayer (Inst); Bio-Based Industries (Inst); Bristol-Myers Squibb (Inst); Cancer Australia (Inst); Cancer Institute NSW (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); National Health and Medical Research Council (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Specialised Therapeutics (Inst)
 
Val Gebski
Research Funding - Specialised Therapeutics (Inst)
 
David Goldstein
Research Funding - Celgene; Celgene (Inst)